Lung cancer screening
Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …
Exploring histopathological and serum biomarkers in lung adenocarcinoma: Clinical applications and translational opportunities
MA Ortega, F Navarro, L Pekarek… - International …, 2022 - spandidos-publications.com
Lung cancer represents one of the most common neoplasms and the main cause of cancer‑
associated death worldwide. Its relationship with different risk factors such as tobacco, which …
associated death worldwide. Its relationship with different risk factors such as tobacco, which …
Assistive AI in lung cancer screening: A retrospective multinational study in the United States and Japan
Purpose To evaluate the impact of an artificial intelligence (AI) assistant for lung cancer
screening on multinational clinical workflows. Materials and Methods An AI assistant for lung …
screening on multinational clinical workflows. Materials and Methods An AI assistant for lung …
Impact of an Epstein-Barr virus serology-based screening program on nasopharyngeal carcinoma mortality: a cluster-randomized controlled trial
WJ Chen, X Yu, YQ Lu, RM Pfeiffer, W Ling… - Journal of Clinical …, 2025 - ascopubs.org
PURPOSE Screening for nasopharyngeal carcinoma (NPC) has shown an improvement in
early detection and survival rates of NPC in endemic regions. It is critical to evaluate whether …
early detection and survival rates of NPC in endemic regions. It is critical to evaluate whether …
COPD, pulmonary fibrosis and ILAs in aging smokers: the paradox of striking different responses to the major risk factors
B Beghé, S Cerri, LM Fabbri, A Marchioni - International Journal of …, 2021 - mdpi.com
Aging and smoking are associated with the progressive development of three main
pulmonary diseases: chronic obstructive pulmonary disease (COPD), interstitial lung …
pulmonary diseases: chronic obstructive pulmonary disease (COPD), interstitial lung …
Social disparities in lung cancer risk and screening
V Raman, V Yong, CP Erkmen… - Thoracic surgery …, 2022 - thoracic.theclinics.com
Lung cancer is the leading cause of mortality related to cancer in the United States and
globally. 1 The American Cancer Society estimates that in 2021, about 235,760 new cases …
globally. 1 The American Cancer Society estimates that in 2021, about 235,760 new cases …
[HTML][HTML] Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review
MF Chen, JE Chaft - Translational Lung Cancer Research, 2023 - ncbi.nlm.nih.gov
Early-stage anaplastic lymphoma kinase (ALK)-positive lung cancer: a narrative review - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …
Validation of a deep learning–based model to predict lung cancer risk using chest radiographs and electronic medical record data
VK Raghu, AS Walia, AN Zinzuwadia… - JAMA Network …, 2022 - jamanetwork.com
Importance Lung cancer screening with chest computed tomography (CT) prevents lung
cancer death; however, fewer than 5% of eligible Americans are screened. CXR-LC, an …
cancer death; however, fewer than 5% of eligible Americans are screened. CXR-LC, an …
[HTML][HTML] Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary …
G Pasello, D Scattolin, L Bonanno, F Caumo… - Cancer Treatment …, 2023 - Elsevier
Lung cancer (LC) is the leading cause of cancer-related death worldwide, mostly because
the lack of a screening program so far. Although smoking cessation has a central role in LC …
the lack of a screening program so far. Although smoking cessation has a central role in LC …
Predictors of invasive adenocarcinomas among pure ground-glass nodules less than 2 cm in diameter
Simple Summary Benign lesions, atypical adenomatous hyperplasia, and malignancies
such as adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive …
such as adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive …